What is the current Price Target for the Aeglea BioTherapeutics Inc stock?

The average Aeglea BioTherapeutics Inc target price is $124.44. This is 45.22% higher than the current stock price. The highest price target is 61.75%, the lowest is 14.33%. 16 Analysts have issued a price target Aeglea BioTherapeutics Inc 2027 .

How high will the Aeglea BioTherapeutics Inc stock rise?

No reliable answer can be given as to how high the Aeglea BioTherapeutics Inc stock will rise. The performance of stocks, including the Aeglea BioTherapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Aeglea BioTherapeutics Inc stock today?

The performance of Aeglea BioTherapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Aeglea BioTherapeutics Inc stock fall?

The decline in Aeglea BioTherapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Aeglea BioTherapeutics Inc Forecast, price target & analysts

$85.69

1.61%

Nasdaq, Sep 25, 04:00 pm EDT. Closed.

ISIN

US00773J1034

Symbol

SYRE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Aeglea BioTherapeutics Inc Target price 2026 - Analyst rating & recommendation

Aeglea BioTherapeutics Inc Classifications & Recommendation

Buy

91%

Hold

Aeglea BioTherapeutics Inc Price Target

Target Price	$124.44
Price	$85.69
Potential	45.22% register free of charge
Number of Estimates	16

	16 Analysts have issued a price target Aeglea BioTherapeutics Inc 2027 . The average Aeglea BioTherapeutics Inc target price is $124.44. This is 45.22% register free of charge higher than the current stock price. The highest price target is $138.60 61.75% register free of charge , the lowest is $97.97 14.33% register free of charge .
	A rating was issued by 23 analysts: 21 Analysts recommend Aeglea BioTherapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Aeglea BioTherapeutics Inc stock has an average upside potential 2027 of 45.22% register free of charge . Most analysts recommend the Aeglea BioTherapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-2.42	-2.83
	45.25%	16.94%
P/E		negative

17 Analysts have issued a Aeglea BioTherapeutics Inc forecast for earnings per share. The average Aeglea BioTherapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.42	45.25%
2026	$-2.83 16.94% unlock
2027	$-3.55 25.44% unlock
2028	$-4.03 13.52% unlock
2029	$-4.18 3.72% unlock
2030	$-4.06 2.87% unlock
2031	$-3.13 22.91% unlock
2032	$1.44 146.01% unlock
2033	$10.43 624.31% unlock

Current
2026	-30.27 25.46% unlock
2027	-24.17 20.15% unlock
2028	-21.25 12.08% unlock
2029	-20.48 3.62% unlock
2030	-21.11 3.08% unlock
2031	-27.38 29.70% unlock
2032	59.37 316.84% unlock
2033	8.21 86.17% unlock

Aeglea BioTherapeutics Inc...

Current Aeglea BioTherapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Wedbush	Locked ➜ Locked	Locked	Sep 09 2026
BTIG	Locked ➜ Locked	Locked	Sep 08 2026
Deutsche Bank	Locked ➜ Locked	Locked	Aug 26 2026
BTIG	Locked ➜ Locked	Locked	Aug 26 2026
Wedbush	Locked ➜ Locked	Locked	Aug 26 2026
BTIG	Locked ➜ Locked	Locked	Aug 11 2026
Guggenheim	Locked ➜ Locked	Locked	Aug 05 2026

Analyst Rating	Date
Locked Wedbush: Locked ➜ Locked	Sep 09 2026
Locked BTIG: Locked ➜ Locked	Sep 08 2026
Locked Deutsche Bank: Locked ➜ Locked	Aug 26 2026
Locked BTIG: Locked ➜ Locked	Aug 26 2026
Locked Wedbush: Locked ➜ Locked	Aug 26 2026
Locked BTIG: Locked ➜ Locked	Aug 11 2026
Locked Guggenheim: Locked ➜ Locked	Aug 05 2026

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now